Milestones ahead as the US FDA takes charge of synthetic nicotine regulation

The passage of the $1.5tn omnibus spending bill and its rider giving the US Food and Drug Administration (FDA) authority to regulate synthetic nicotine products in the same way that tobacco products are regulated will irrevocably change the US vaping market.

Now that president Joe Biden has signed the bill into law, there are a number of major milestones to look out for over the coming months. ECigIntelligence has put together a timeline outlining the major points to look out for over the summer as the FDA brings synthetic nicotine into the PMTA process.

Subscribe to our newsletter

Join in to hear about news, events, and podcasts in the sector

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Email*

Company Name*

Name*

– ECigIntelligence staff

ECigIntelligence

This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.